This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Illumina Corporation. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Gordon Bean: Innovator in Nucleic Acid Indexing Technologies
Introduction
Gordon Bean is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of nucleic acid indexing technologies. With a total of 4 patents to his name, Bean's work has advanced the methods used in genetic research and analysis.
Latest Patents
Gordon Bean's latest patents include innovative solutions for indexing polynucleotide samples. One of his notable patents is focused on universal short adapters for indexing of polynucleotide samples. This invention involves index oligonucleotides designed to identify sources of nucleic acid samples. The disclosed embodiments detail methods, apparatus, systems, and computer program products for creating and utilizing these index oligonucleotides. The index oligonucleotides feature a set of index sequences, with a Hamming distance between any two sequences meeting specific criteria. Additionally, systems and products are provided for determining a sequence of interest using these index oligonucleotides.
Another significant patent by Bean is centered on optimal index sequences for multiplex massively parallel sequencing. Similar to his previous work, this invention also involves index oligonucleotides that identify sources of nucleic acid samples. The methods and systems described aim to enhance the efficiency and accuracy of sequencing processes.
Career Highlights
Gordon Bean is currently associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to collaborate with other talented professionals in the industry.
Collaborations
Some of his notable coworkers include Eric Hans Vermaas and Ryan Kelley. Their combined expertise contributes to the innovative projects at Illumina Corporation.
Conclusion
Gordon Bean's contributions to nucleic acid indexing technologies have made a significant impact on genetic research. His patents reflect a commitment to advancing the field and improving methodologies for sequencing. His work continues to influence the future of genomics and biotechnology.